Clinical application and progress of quantitative functional magnetic resonance imaging in prostate cancer.
10.11817/j.issn.1672-7347.2021.200316
- Author:
Mengsi LI
1
;
Wenzheng LI
2
Author Information
1. Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008, China. 15111134264@163.com.
2. Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008, China. wenzheng727@163.com.
- Publication Type:Journal Article
- Keywords:
diffusion kurtosis imaging;
diffusion tensor imaging;
diffusion weighted imaging;
dynamic contrast enhanced magnetic resonance imaging;
intravoxel incoherent motion diffusion imaging;
magnetic resonance elastography;
magnetic resonance spectroscopy;
prostate cancer
- MeSH:
Diffusion Magnetic Resonance Imaging;
Diffusion Tensor Imaging;
Humans;
Magnetic Resonance Imaging;
Male;
Motion;
Prostatic Neoplasms/diagnostic imaging*
- From:
Journal of Central South University(Medical Sciences)
2021;46(4):414-420
- CountryChina
- Language:English
-
Abstract:
Magnetic resonance imaging (MRI) is a very important imaging method for diagnosis and treatment of prostate cancer (PCa) in clinical practice. As functional MRI is growing and maturing, its quantitative parameters are expected to enhance the clinical value of MRI furtherly. Intravoxel incoherent motion diffusion imaging, diffusion tensor imaging, and diffusion kurtosis imaging, which were derived from diffusion weighted imaging, have provided richer and more accurate parameters. The newly-developed magnetic resonance elastography can complement the mechanical characteristics of PCa.
